Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment (Q36336684)

13 August 2017

1 reference

title

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment (English)

1 reference

ovarian hyperstimulation syndrome

13 August 2017

main subject

1 reference

1 reference

Navot D

1 reference

13 August 2017

Bergh PA

series ordinal

1 reference

13 August 2017

Laufer N

series ordinal

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 August 1992

1 reference

13 August 2017

published in

Fertility and Sterility

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

249-261

1 reference

Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ovarian function for multiple follicle maturation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ovarian hyperstimulation syndrome: an update review.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Induction of ovulation with menotropins in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Treatment of anovulation with menotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Risk factors and prognostic variables in the ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Diagnosis-specific serum 17 beta-estradiol (E2) upper limits for treatment with menotropins using a 125I direct E2 assay

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ultrasound in gonadotrophin therapy: a better predictor of ovarian hyperstimulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Failure of body mass index or body weight to influence markedly the response to ovarian hyperstimulation in normal cycling women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

CLINICAL TRIAL OF HUMAN GONADOTROPHINS. I. THE EFFECT OF PITUITARY AND URINARY FOLLICLE STIMULATING HORMONE AND CHORIONIC GONADOTROPHIN ON PATIENTS WITH IDIOPATHIC SECONDARY AMENORRHOEA

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

The Use of Gonadotropins for the Induction of Ovulation in Women with Polycystic Ovarian Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Severe ovarian hyperstimulation syndrome from treatment with urinary follicle-stimulating hormone: two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

The use of follicle-stimulating hormone for controlled ovarian hyperstimulation in in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Dynamics of follicular growth in the human: a model from preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Pulsatile luteinizing hormone-releasing hormone therapy in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Induction of ovulation in polycystic ovary syndrome with a combination of a luteinizing hormone-releasing hormone analog and exogenous gonadotropins

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ovarian hyperstimulation syndrome following D-Trp-6 luteinizing hormone-releasing hormone microcapsules and menotropin for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

LH surge induction by GnRH agonist at the time of ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Cryopreservation of zygotes and early cleaved human embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Embryonic development and pregnancy from fresh and cryopreserved sibling pronucleate human zygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Clinical status of human embryo cryopreservation in the United States of America

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Factors influencing the success rate of human embryo freezing in an in vitro fertilization and embryo transfer program.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Very high serum estradiol levels are not detrimental to clinical outcome of in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

An insight into early reproductive processes through the in vivo model of ovum donation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Transfer of cryopreserved-thawed embryos: the natural cycle versus controlled preparation of the endometrium with gonadotropin-releasing hormone agonist and exogenous estradiol and progesterone (GEEP)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Severe ovarian hyperstimulation following follicular aspiration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Severe ovarian hyperstimulation syndrome: a reevaluated therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ovarian hyperstimulation presenting as acute hydrothorax after in vitro fertilization

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Abdominal paracentesis for the ovarian hyperstimulation syndrome with severe pulmonary compromise.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Negative influences of ascites on the cardiac function of cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Hemodynamics in the cirrhotic patient during paracentesis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Treatment of ovarian hyperstimulation syndrome: the physiologic basis for a modified approach

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Modern management of ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Clinical, endocrinologic, and intraovarian prostaglandin F responses to H-1 receptor blockade in the ovarian hyperstimulation syndrome: Studies in the rabbit model

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Acute oligo-anuria during ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Renal syndromes associated with nonsteroidal antiinflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Serotonin and the ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Ovarian renin production in vitro and in vivo: characterization and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Stimulation of prostaglandin E synthesis in cultured human umbilical vein smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Effects of angiotensin II and some analogues on vascular permeability in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Blockage of Ovulation by an Angiotensin Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

Anesthetic considerations for severe ovarian hyperstimulation syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955188-7

7 January 2021

10.1016/S0015-0282(16)55188-7

Identifiers

DOI

0 references

1 reference